The BRAIN Foundation's Synchrony Symposia is the first and only international symposium on translational research for Autism Spectrum Disorder (“ASD”)…
Appia Rare Earths & Uranium (CSE: API) (OTCQX: APAAF) (FSE: A0I0), a Canadian company in the rare earth element and uranium…
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has announced that…
Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left…
In line with recent emphasis on the growing importance of nanotechnology in the US, Clene Nanomedicine innovated its investigational drug,…
Digital engagement innovator Electronic Servitor Publication Network is devoted to using advanced automated, interactive technological solutions to help clients build…
Lexaria recently announced its intention to launch new human and animal studies exploring its patented DehydraTECH(TM) technology on GLP-1 drugs…
Appia recently entered into a definitive agreement to acquire up to a 70% interest in the 17,551.07-hectare PCH Project located…
Sekur Private Data (CSE: SKUR) (OTCQX: SWISF) (FSE: GDT0), a leading Swiss-hosted secure and private communications platform, is spotlighted in…
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has granted a new global, exclusive license to SulfoSyn…